CF
59
3
TXT
48
2
UA
45
-3
EFX
32
2
STI
47
-12
EQR
54
-2
EXR
57
-2
WDC
41
-2
XOM
47
5
TRV
53
-3
DNB
78
6
XEL
67
2
EQIX
60
-2
EXPE
88
2
QRVO
6
2
VFC
47
-5
EW
37
-2
CVS
48
3
IFF
53
2
MCO
73
3
CF
59
3
TXT
48
2
UA
45
-3
EFX
32
2
STI
47
-12
EQR
54
-2
EXR
57
-2
WDC
41
-2
XOM
47
5
TRV
53
-3
DNB
78
6
XEL
67
2
EQIX
60
-2
EXPE
88
2
QRVO
6
2
VFC
47
-5
EW
37
-2
CVS
48
3
IFF
53
2
MCO
73
3
Financhill
Back

Novavax Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
24

NVAX
Novavax

Last Price:
8.16
Seasonality Move:
18.22%
Sell
44

HALO
Halozyme Therapeutics

Last Price:
45.27
Seasonality Move:
17.34%
Sell
24
Novavax (NVAX) is a Sell

Is Novavax a Buy, Sell or Hold?

  • The current Novavax [NVAX] share price is $8.06. The Score for NVAX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • NVAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.76. The Score for HALO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVAX Stock Price Chart

What is Novavax's stock price today?

  • The Novavax share price today is $8.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.94 Sell
Relative Strength Index (14 RSI): 35.75 Sell
Chaikin Money Flow: 1667198 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.2 - 10.1) Sell
Bollinger Bands (100): (9.91 - 14.09) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.04 Sell
Relative Strength Index (14 RSI): 35.09 Sell
Chaikin Money Flow: 1074433 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.74 - 58.56) Sell
Bollinger Bands (100): (51.51 - 60.57) Sell

NVAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.96 Buy
20-day SMA: 8.9 Sell
50-day SMA: 11.03 Sell
200-day SMA: 10.05 Sell
8-day EMA: 8.08 Sell
20-day EMA: 8.91 Sell
50-day EMA: 10.33 Sell
200-day EMA: 10.68 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.51 Sell
20-day SMA: 53.43 Sell
50-day SMA: 55.29 Sell
200-day SMA: 49.09 Sell
8-day EMA: 49.51 Sell
20-day EMA: 52.58 Sell
50-day EMA: 54.37 Sell
200-day EMA: 50.54 Sell

Novavax Earnings Growth & NVAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.39 per share, and an increase next year of $2.35 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Novavax Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):